| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coccidioidomycosis | 39 | 2021 | 46 | 9.460 |
Why?
|
| Coccidioides | 46 | 2021 | 51 | 9.440 |
Why?
|
| Fungal Vaccines | 26 | 2020 | 41 | 5.270 |
Why?
|
| Antigens, Fungal | 12 | 2019 | 32 | 2.290 |
Why?
|
| CARD Signaling Adaptor Proteins | 6 | 2020 | 11 | 1.700 |
Why?
|
| Arabidopsis | 5 | 2023 | 88 | 1.640 |
Why?
|
| Plant Proteins | 5 | 2017 | 93 | 1.400 |
Why?
|
| Plants, Genetically Modified | 9 | 2022 | 42 | 1.280 |
Why?
|
| Mice | 45 | 2022 | 5668 | 1.250 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2016 | 15 | 1.210 |
Why?
|
| Antibodies, Fungal | 8 | 2019 | 23 | 1.200 |
Why?
|
| Adjuvants, Immunologic | 4 | 2019 | 106 | 1.170 |
Why?
|
| T-Lymphocytes | 6 | 2017 | 341 | 1.110 |
Why?
|
| Araceae | 3 | 2017 | 3 | 1.040 |
Why?
|
| Lung | 8 | 2020 | 413 | 0.960 |
Why?
|
| Animals | 50 | 2022 | 14307 | 0.940 |
Why?
|
| Immunity, Innate | 4 | 2019 | 135 | 0.920 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 38 | 0.910 |
Why?
|
| HLA-DR4 Antigen | 3 | 2018 | 20 | 0.900 |
Why?
|
| GTP Cyclohydrolase | 1 | 2022 | 4 | 0.900 |
Why?
|
| Lectins, C-Type | 3 | 2020 | 35 | 0.890 |
Why?
|
| Huntington Disease | 1 | 2022 | 25 | 0.890 |
Why?
|
| Glucans | 2 | 2019 | 6 | 0.860 |
Why?
|
| Mice, Inbred C57BL | 21 | 2021 | 1530 | 0.860 |
Why?
|
| Adaptive Immunity | 2 | 2019 | 27 | 0.830 |
Why?
|
| Flowers | 2 | 2023 | 16 | 0.810 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2017 | 55 | 0.770 |
Why?
|
| Recombinant Proteins | 13 | 2021 | 485 | 0.770 |
Why?
|
| Vaccines, Combined | 1 | 2020 | 11 | 0.760 |
Why?
|
| Erythropoietin | 5 | 2021 | 37 | 0.750 |
Why?
|
| Chitin | 3 | 2019 | 19 | 0.740 |
Why?
|
| Gene Expression Regulation, Plant | 4 | 2017 | 58 | 0.730 |
Why?
|
| Serologic Tests | 3 | 2019 | 43 | 0.730 |
Why?
|
| Precipitins | 1 | 2019 | 1 | 0.730 |
Why?
|
| Saccharomycetales | 1 | 2019 | 7 | 0.720 |
Why?
|
| Vaccines, Subunit | 3 | 2019 | 30 | 0.710 |
Why?
|
| Vaccines, Attenuated | 7 | 2016 | 72 | 0.710 |
Why?
|
| Th1 Cells | 4 | 2018 | 87 | 0.700 |
Why?
|
| Cytokines | 12 | 2020 | 569 | 0.700 |
Why?
|
| Protozoan Vaccines | 1 | 2018 | 15 | 0.680 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2016 | 91 | 0.660 |
Why?
|
| Interferon-gamma | 3 | 2016 | 235 | 0.650 |
Why?
|
| Nitric Oxide | 3 | 2018 | 287 | 0.590 |
Why?
|
| Gibberellins | 1 | 2016 | 6 | 0.580 |
Why?
|
| Fungal Proteins | 8 | 2019 | 130 | 0.570 |
Why?
|
| Genes, Plant | 2 | 2016 | 17 | 0.570 |
Why?
|
| Molecular Sequence Data | 18 | 2014 | 1490 | 0.550 |
Why?
|
| Amino Acid Sequence | 13 | 2017 | 1124 | 0.540 |
Why?
|
| Flow Cytometry | 2 | 2018 | 392 | 0.540 |
Why?
|
| Indoleacetic Acids | 2 | 2014 | 8 | 0.520 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 197 | 0.520 |
Why?
|
| Immunologic Memory | 2 | 2013 | 38 | 0.510 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 4 | 0.500 |
Why?
|
| Lung Diseases, Fungal | 5 | 2020 | 20 | 0.490 |
Why?
|
| Plant Growth Regulators | 1 | 2014 | 16 | 0.490 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 25 | 0.490 |
Why?
|
| Gene Deletion | 3 | 2018 | 156 | 0.480 |
Why?
|
| Interleukin-10 | 1 | 2013 | 69 | 0.470 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2012 | 13 | 0.450 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 608 | 0.450 |
Why?
|
| Signal Transduction | 6 | 2020 | 1802 | 0.440 |
Why?
|
| Complement C5a | 1 | 2012 | 2 | 0.440 |
Why?
|
| Alkaloids | 1 | 2012 | 38 | 0.440 |
Why?
|
| Astragalus Plant | 1 | 2012 | 1 | 0.430 |
Why?
|
| Hygromycin B | 1 | 2012 | 1 | 0.430 |
Why?
|
| Phleomycins | 1 | 2012 | 2 | 0.430 |
Why?
|
| Selenium Compounds | 1 | 2012 | 11 | 0.430 |
Why?
|
| Mice, Knockout | 9 | 2016 | 897 | 0.430 |
Why?
|
| Cinnamates | 1 | 2012 | 5 | 0.430 |
Why?
|
| Drug Resistance, Fungal | 1 | 2012 | 32 | 0.420 |
Why?
|
| Gene Expression Regulation, Fungal | 4 | 2010 | 72 | 0.410 |
Why?
|
| Th2 Cells | 1 | 2011 | 56 | 0.410 |
Why?
|
| Genetic Markers | 1 | 2012 | 118 | 0.410 |
Why?
|
| Interleukin-17 | 5 | 2016 | 54 | 0.410 |
Why?
|
| Plant Leaves | 4 | 2017 | 110 | 0.400 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2018 | 286 | 0.400 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 1300 | 0.400 |
Why?
|
| Vaccines, Synthetic | 8 | 2018 | 72 | 0.370 |
Why?
|
| Nicotine | 1 | 2012 | 238 | 0.370 |
Why?
|
| Regeneration | 1 | 2010 | 20 | 0.370 |
Why?
|
| Phagocytosis | 3 | 2010 | 64 | 0.370 |
Why?
|
| Lymphocyte Activation | 6 | 2016 | 222 | 0.370 |
Why?
|
| Selenium | 1 | 2012 | 144 | 0.360 |
Why?
|
| Macrophages | 4 | 2020 | 431 | 0.360 |
Why?
|
| Mice, Inbred BALB C | 12 | 2019 | 649 | 0.360 |
Why?
|
| Humans | 32 | 2022 | 34853 | 0.340 |
Why?
|
| Peptides | 3 | 2023 | 308 | 0.340 |
Why?
|
| Folic Acid | 2 | 2022 | 46 | 0.330 |
Why?
|
| Vaccination | 5 | 2016 | 259 | 0.320 |
Why?
|
| Antifungal Agents | 2 | 2019 | 147 | 0.300 |
Why?
|
| Candida albicans | 2 | 2018 | 163 | 0.290 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 15 | 0.280 |
Why?
|
| Receptors, Interleukin-17 | 3 | 2016 | 8 | 0.270 |
Why?
|
| Female | 16 | 2020 | 19873 | 0.260 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2012 | 249 | 0.260 |
Why?
|
| beta-Glucosidase | 2 | 2001 | 6 | 0.250 |
Why?
|
| Survival Analysis | 5 | 2018 | 322 | 0.250 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 968 | 0.250 |
Why?
|
| Receptors, Interferon | 2 | 2016 | 14 | 0.250 |
Why?
|
| Mycoses | 2 | 2016 | 29 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2019 | 445 | 0.240 |
Why?
|
| Asialoglycoproteins | 2 | 2014 | 3 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 605 | 0.240 |
Why?
|
| Spores, Fungal | 3 | 2016 | 17 | 0.240 |
Why?
|
| Pollen | 1 | 2023 | 5 | 0.240 |
Why?
|
| Urease | 3 | 2013 | 15 | 0.240 |
Why?
|
| Cell Wall | 3 | 2006 | 53 | 0.230 |
Why?
|
| Blastomyces | 2 | 2014 | 2 | 0.230 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2022 | 9 | 0.230 |
Why?
|
| Cysteine | 1 | 2023 | 88 | 0.230 |
Why?
|
| Cross Infection | 1 | 2022 | 38 | 0.220 |
Why?
|
| Acinetobacter baumannii | 1 | 2022 | 33 | 0.220 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 180 | 0.220 |
Why?
|
| Base Sequence | 6 | 2014 | 932 | 0.210 |
Why?
|
| Carbon | 1 | 2022 | 95 | 0.210 |
Why?
|
| Proteomics | 2 | 2022 | 302 | 0.200 |
Why?
|
| Virulence | 7 | 2018 | 221 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 2 | 2012 | 30 | 0.200 |
Why?
|
| Immunoglobulin M | 1 | 2001 | 81 | 0.200 |
Why?
|
| Southwestern United States | 2 | 2019 | 35 | 0.200 |
Why?
|
| Genetic Engineering | 1 | 2020 | 31 | 0.190 |
Why?
|
| Polysaccharides | 1 | 2020 | 55 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 6 | 2012 | 455 | 0.180 |
Why?
|
| Neutrophils | 3 | 2016 | 124 | 0.180 |
Why?
|
| Macrophage Activation | 1 | 2020 | 52 | 0.180 |
Why?
|
| Drug Carriers | 1 | 2020 | 121 | 0.180 |
Why?
|
| Lipids | 1 | 2021 | 222 | 0.180 |
Why?
|
| Cryptococcosis | 1 | 2020 | 35 | 0.180 |
Why?
|
| Biofilms | 2 | 2018 | 166 | 0.180 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 182 | 0.170 |
Why?
|
| Cryptococcus neoformans | 1 | 2020 | 55 | 0.170 |
Why?
|
| Gold | 1 | 2020 | 134 | 0.170 |
Why?
|
| Immunoblotting | 4 | 2012 | 170 | 0.170 |
Why?
|
| Tularemia | 2 | 2018 | 114 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 231 | 0.170 |
Why?
|
| Community-Acquired Infections | 1 | 2019 | 24 | 0.170 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 52 | 0.170 |
Why?
|
| Antigens, Protozoan | 1 | 2018 | 71 | 0.160 |
Why?
|
| Phagosomes | 1 | 2018 | 30 | 0.160 |
Why?
|
| Zea mays | 1 | 2019 | 67 | 0.160 |
Why?
|
| Stroke | 1 | 2021 | 274 | 0.160 |
Why?
|
| Amides | 1 | 2018 | 66 | 0.160 |
Why?
|
| Mutagenesis | 2 | 2012 | 87 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2018 | 44 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 180 | 0.160 |
Why?
|
| Protein Binding | 2 | 2018 | 913 | 0.160 |
Why?
|
| Male | 5 | 2020 | 18870 | 0.160 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 310 | 0.150 |
Why?
|
| Vaccines, Inactivated | 1 | 2017 | 14 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 34 | 0.150 |
Why?
|
| Formaldehyde | 1 | 2017 | 33 | 0.150 |
Why?
|
| Molecular Weight | 3 | 2002 | 161 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 416 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 65 | 0.150 |
Why?
|
| Meristem | 1 | 2016 | 6 | 0.150 |
Why?
|
| Oligopeptides | 2 | 2014 | 97 | 0.150 |
Why?
|
| Histoplasma | 2 | 2014 | 5 | 0.150 |
Why?
|
| Databases, Genetic | 1 | 2017 | 90 | 0.140 |
Why?
|
| Interleukins | 1 | 2016 | 28 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 63 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2016 | 35 | 0.140 |
Why?
|
| Genes, Reporter | 2 | 2014 | 132 | 0.140 |
Why?
|
| Respiratory Tract Infections | 2 | 2006 | 31 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 229 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 430 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 528 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 180 | 0.140 |
Why?
|
| Calnexin | 1 | 2015 | 1 | 0.130 |
Why?
|
| Ascomycota | 1 | 2015 | 15 | 0.130 |
Why?
|
| Epoetin Alfa | 1 | 2014 | 2 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 181 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 251 | 0.130 |
Why?
|
| Francisella tularensis | 1 | 2016 | 115 | 0.130 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 122 | 0.130 |
Why?
|
| Blotting, Southern | 4 | 2002 | 66 | 0.130 |
Why?
|
| Biochemistry | 1 | 2014 | 12 | 0.130 |
Why?
|
| Genome, Fungal | 3 | 2010 | 21 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 484 | 0.130 |
Why?
|
| Gene Expression | 5 | 2020 | 639 | 0.130 |
Why?
|
| Epitopes | 1 | 2015 | 145 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 179 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 275 | 0.130 |
Why?
|
| DNA, Complementary | 2 | 2012 | 175 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2018 | 294 | 0.120 |
Why?
|
| Blastomycosis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Histoplasmosis | 1 | 2014 | 2 | 0.120 |
Why?
|
| Immunity, Active | 1 | 2013 | 6 | 0.120 |
Why?
|
| Multigene Family | 1 | 2014 | 105 | 0.120 |
Why?
|
| Plant Roots | 2 | 2014 | 153 | 0.120 |
Why?
|
| Endemic Diseases | 1 | 2014 | 22 | 0.120 |
Why?
|
| Amidine-Lyases | 1 | 2013 | 1 | 0.120 |
Why?
|
| Genes, Fungal | 3 | 2002 | 38 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 84 | 0.120 |
Why?
|
| Ammonia | 1 | 2013 | 17 | 0.120 |
Why?
|
| Light | 1 | 2014 | 180 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 756 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2018 | 653 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2012 | 84 | 0.110 |
Why?
|
| Methylation | 1 | 2012 | 102 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 20 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2012 | 11 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2012 | 82 | 0.110 |
Why?
|
| DNA, Plant | 1 | 2012 | 13 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2012 | 68 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 160 | 0.110 |
Why?
|
| Phagocytes | 1 | 2011 | 5 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2014 | 834 | 0.100 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2011 | 10 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 164 | 0.100 |
Why?
|
| RNA Interference | 1 | 2012 | 225 | 0.100 |
Why?
|
| Glycosylation | 3 | 2020 | 92 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 25 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2008 | 33 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2014 | 486 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 146 | 0.100 |
Why?
|
| Protein Engineering | 2 | 2014 | 40 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 103 | 0.100 |
Why?
|
| Hybridization, Genetic | 1 | 2010 | 11 | 0.100 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 44 | 0.090 |
Why?
|
| Hydrazones | 1 | 2009 | 5 | 0.090 |
Why?
|
| Succinimides | 1 | 2009 | 9 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2010 | 30 | 0.090 |
Why?
|
| Niacinamide | 1 | 2009 | 10 | 0.090 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 5 | 0.090 |
Why?
|
| Mitosporic Fungi | 1 | 2009 | 4 | 0.090 |
Why?
|
| Ovalbumin | 1 | 2009 | 43 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 342 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1426 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 143 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1149 | 0.090 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 49 | 0.090 |
Why?
|
| Abscisic Acid | 1 | 2008 | 5 | 0.090 |
Why?
|
| Vaccines | 1 | 2009 | 49 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2009 | 140 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2010 | 420 | 0.080 |
Why?
|
| Spleen | 3 | 2016 | 192 | 0.080 |
Why?
|
| Mutation | 4 | 2006 | 1023 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 249 | 0.080 |
Why?
|
| Transformation, Genetic | 3 | 2002 | 19 | 0.080 |
Why?
|
| Candidiasis | 2 | 2018 | 85 | 0.080 |
Why?
|
| Arginase | 1 | 2007 | 12 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1152 | 0.080 |
Why?
|
| Immune System | 1 | 2007 | 40 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2007 | 100 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 577 | 0.070 |
Why?
|
| Colony Count, Microbial | 3 | 2011 | 66 | 0.070 |
Why?
|
| Melanins | 1 | 2006 | 32 | 0.070 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2005 | 5 | 0.070 |
Why?
|
| Virulence Factors | 1 | 2007 | 113 | 0.070 |
Why?
|
| Gravitropism | 1 | 2005 | 6 | 0.070 |
Why?
|
| Immunization | 3 | 2019 | 90 | 0.070 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2006 | 19 | 0.070 |
Why?
|
| Opsonin Proteins | 1 | 2005 | 1 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2005 | 31 | 0.070 |
Why?
|
| Disease Progression | 1 | 2007 | 580 | 0.060 |
Why?
|
| Fungi | 1 | 2005 | 86 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 600 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 67 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 109 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 642 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2019 | 436 | 0.060 |
Why?
|
| Glucan Endo-1,3-beta-D-Glucosidase | 1 | 2003 | 2 | 0.060 |
Why?
|
| Cell Survival | 2 | 2017 | 818 | 0.060 |
Why?
|
| Respiratory System | 1 | 2002 | 21 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 49 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2002 | 48 | 0.050 |
Why?
|
| Laminin | 1 | 2002 | 59 | 0.050 |
Why?
|
| Fibronectins | 1 | 2002 | 65 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 100 | 0.050 |
Why?
|
| Gene Order | 2 | 2013 | 15 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 111 | 0.050 |
Why?
|
| Vaccines, DNA | 1 | 2001 | 23 | 0.050 |
Why?
|
| DNA, Fungal | 3 | 2009 | 40 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 51 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2013 | 46 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 69 | 0.050 |
Why?
|
| Chitin Synthase | 1 | 2001 | 4 | 0.050 |
Why?
|
| Glucosyltransferases | 1 | 2001 | 7 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2020 | 2 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 282 | 0.050 |
Why?
|
| Mammals | 1 | 2021 | 96 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2016 | 562 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2014 | 350 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 142 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2020 | 80 | 0.050 |
Why?
|
| Genome, Plant | 1 | 2020 | 26 | 0.050 |
Why?
|
| Ornithine Decarboxylase | 1 | 2000 | 10 | 0.050 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 9 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2000 | 39 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2020 | 53 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 112 | 0.050 |
Why?
|
| Leukocytes | 1 | 2020 | 68 | 0.040 |
Why?
|
| Immunodominant Epitopes | 2 | 2011 | 27 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 35 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 391 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 220 | 0.040 |
Why?
|
| Hyphae | 1 | 2018 | 36 | 0.040 |
Why?
|
| Plankton | 1 | 2018 | 12 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gene Library | 1 | 2018 | 55 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 34 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 91 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2018 | 69 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2018 | 171 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 53 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 115 | 0.040 |
Why?
|
| Plasmids | 1 | 2018 | 233 | 0.040 |
Why?
|
| Transfection | 1 | 2018 | 496 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2016 | 23 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 47 | 0.040 |
Why?
|
| Immunity | 1 | 2016 | 51 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 139 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2010 | 328 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 650 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 25 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 64 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 195 | 0.030 |
Why?
|
| Phylogeny | 2 | 2009 | 612 | 0.030 |
Why?
|
| Animals, Congenic | 1 | 2014 | 11 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2014 | 7 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 48 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 1268 | 0.030 |
Why?
|
| Staurosporine | 1 | 2013 | 35 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 32 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 154 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2014 | 112 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2013 | 194 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 117 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 260 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 17 | 0.030 |
Why?
|
| Receptors, Erythropoietin | 1 | 2012 | 7 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 173 | 0.030 |
Why?
|
| Paracoccidioidomycosis | 1 | 2011 | 4 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 143 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 57 | 0.030 |
Why?
|
| North America | 1 | 2011 | 60 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 878 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 116 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 86 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 32 | 0.020 |
Why?
|
| Metagenomics | 1 | 2010 | 32 | 0.020 |
Why?
|
| Synteny | 1 | 2009 | 14 | 0.020 |
Why?
|
| Onygenales | 1 | 2009 | 2 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2009 | 9 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1349 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2009 | 42 | 0.020 |
Why?
|
| California | 1 | 2010 | 436 | 0.020 |
Why?
|
| Droughts | 1 | 2008 | 20 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 1289 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 338 | 0.020 |
Why?
|
| Genomics | 1 | 2009 | 201 | 0.020 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2007 | 7 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 37 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 298 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2128 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 29 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1681 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1442 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 638 | 0.020 |
Why?
|
| Water | 1 | 2008 | 283 | 0.020 |
Why?
|
| Neurons | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2006 | 16 | 0.020 |
Why?
|
| Vacuoles | 1 | 2006 | 22 | 0.020 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2006 | 10 | 0.020 |
Why?
|
| Plant Shoots | 1 | 2005 | 23 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2005 | 86 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 79 | 0.020 |
Why?
|
| Gene Conversion | 1 | 2005 | 2 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2005 | 9 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 445 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 90 | 0.020 |
Why?
|
| Species Specificity | 1 | 2005 | 233 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 165 | 0.020 |
Why?
|
| DNA Primers | 1 | 2004 | 269 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2001 | 15 | 0.010 |
Why?
|
| Serial Passage | 1 | 2000 | 4 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 75 | 0.010 |
Why?
|
| Culture Media | 1 | 2000 | 84 | 0.010 |
Why?
|
| Putrescine | 1 | 2000 | 25 | 0.010 |
Why?
|
| Mitosis | 1 | 2000 | 97 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 257 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 283 | 0.010 |
Why?
|